Trials / Completed
CompletedNCT00193401
Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer
Phase II Trial of Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- SCRI Development Innovations, LLC · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this phase II trial, we will evaluate the weekly schedule of topotecan in the first-line treatment of elderly and/or poor performance status patients with extensive stage small cell lung cancer. Patients eligible for this trial will be those considered poor candidates for standard combination chemotherapy or other investigational regimens
Detailed description
Upon determination of eligibility, all patients will be receive: * Topotecan
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Topotecan |
Timeline
- Start date
- 2002-08-01
- Primary completion
- 2004-06-01
- Completion
- 2004-11-01
- First posted
- 2005-09-19
- Last updated
- 2010-07-28
Source: ClinicalTrials.gov record NCT00193401. Inclusion in this directory is not an endorsement.